Research on Lyme Disease: Seed Grant Opportunity
Request for Proposals
Deadline: September 1, 2017
The Stanford Lyme Working Group is pleased to announce a new seed grant program to advance research and innovation in Lyme Disease. The seed grant program seeks to broadly stimulate research on Lyme Disease, with the goals of sparking new means of diagnosis, treatment, and prevention of the condition and of examining the impact of Lyme Disease in the lives of individuals, families, and communities. Seed grant proposals may focus on any aspect of Lyme Disease, including (but not limited to) mechanistic studies, clinical treatment approaches and best practices, analyses of existing datasets, strategies for public and clinical education, and translation of evidence into public policy.
Applicants should propose small projects that are feasible, may be completed within one year, and have promise to advance understanding in the field of Lyme Disease. Multi-PI projects are permitted, but one individual must be designated as the project leader.
Amount and Period of Funding
In this initial year of the program, there will be three levels of funding of $10,000, $25,000, and $50,000 for proposed projects. Please note that no indirect or infrastructure costs are provided. Funding for awarded projects will start October 31, 2017 and will be available for one year.
Eligibility
- We welcome applications from all schools on our campus. At least one Principal Investigator must be a School of Medicine faculty member or Instructor. Each faculty member and Instructor can serve as Principal Investigator on only one application associated with this announcement.
- Stanford faculty on the Medical Center Line (MCL), University Tenure Line (UTL), and Non-Tenure Line (NTL), Clinician Educators (CE), Clinical Instructors, and Instructors are invited to apply. Please note that PI waivers are not required for this funding opportunity.
- Graduate students, residents, fellows, and postdoctoral scholars are invited to apply for the $10,000 funding level.
Selection Process
A review committee composed of Stanford faculty and external reviewers will evaluate proposals based on the following criteria:
- Strength of Investigator(s)
- Innovation and potential for translation/application
- Methodological approach
- Salience to strategic priorities
- Overall promise for impact
Awardees will be notified on October 15, 2017. Please note that evaluative ratings and commentary by reviewers will not be provided to applicants.
Requirements
Recipients will be required to write a preliminary report (1 page) at the midpoint and a final 3-page report at termination. Publications resulting from the work should acknowledge the Department of Psychiatry and Behavioral Sciences Lyme Disease Seed Grant Program. Once the winning projects are announced, it is the Principal Investigator’s responsibility to directly consult with Stanford’s Institutional Review Board to ensure that the proposed project is conducted in accordance with all federal, institutional, and ethical guidelines applicable to human subject research. Successful award recipients may be asked to present at a poster session, Grand Rounds, or another venue associated with this announcement.
Application Guidelines
The application portal closed as of midnight, September 1, 2017.
General format recommendations:
File name: “Lastname_Lyme_SeedProject.pdf”
All proposal applications should use at least 11-point font size, 1-inch margins for all pages, with standard word and single line spacing, and include:
- 1-page cover letter summarizing the proposed project and its potential impact on advancing science and/or innovation in the area of Lyme disease
- Up to 3 pages outlining the study aims, rationale, study design and methods, preliminary data (if applicable), and references
- 2-page NIH-style biosketch for the project leader
- 1-page budget justification
- Pages should be numbered consecutively at the bottom right
- The page header should contain the name of the Project Leader and a short title
Proposals that do not conform to the above guidelines will be returned without review.
Please direct all inquiries to:
Aimee-Noelle Swanson PhD
Director of Research Development, Integrity, and Strategy
Department of Psychiatry & Behavioral Sciences
Stanford School of Medicine
aimnoe@stanford.edu
(650) 736-4559